Korean Drug Co., Ltd. (KOSDAQ:014570)
South Korea
· Delayed Price · Currency is KRW 4,230.00
-15.00 (-0.35%)
At close: Apr 28, 2026
Korean Drug Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 6,512 | 2,995 | -4,917 | 11,809 | 9,042 | Upgrade
|
| Depreciation & Amortization | 1,969 | 2,069 | 1,749 | 1,383 | 1,470 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.31 | -3.56 | 3.68 | -2.81 | -1.13 | Upgrade
|
| Loss (Gain) From Sale of Investments | 180.6 | -72.9 | -132.87 | 383.6 | 359.46 | Upgrade
|
| Other Operating Activities | 2,616 | -513.96 | 2,118 | -801.33 | 1,384 | Upgrade
|
| Change in Accounts Receivable | -205.06 | 4,806 | 3,566 | -1,390 | -948.64 | Upgrade
|
| Change in Inventory | 3,507 | -1,605 | -4,657 | -971.78 | -2,149 | Upgrade
|
| Change in Accounts Payable | 672.64 | -1,351 | 1,916 | -3,208 | 550.5 | Upgrade
|
| Change in Other Net Operating Assets | -2,141 | -1,455 | -1,645 | -1,288 | -900.83 | Upgrade
|
| Operating Cash Flow | 13,110 | 4,869 | -1,999 | 5,913 | 8,806 | Upgrade
|
| Operating Cash Flow Growth | 169.27% | - | - | -32.86% | -28.58% | Upgrade
|
| Capital Expenditures | -457 | -1,027 | -5,814 | -6,093 | -1,146 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.32 | 7.46 | 1.12 | 5.86 | 4.5 | Upgrade
|
| Sale (Purchase) of Intangibles | -18.04 | -15.71 | -69.6 | -384.22 | 157.73 | Upgrade
|
| Investment in Securities | -10,182 | -9,830 | 18,159 | 894.66 | -6,980 | Upgrade
|
| Other Investing Activities | 125 | -23.96 | -0 | 175 | -291 | Upgrade
|
| Investing Cash Flow | -10,532 | -10,889 | 12,277 | -5,401 | -8,254 | Upgrade
|
| Long-Term Debt Repaid | -84.21 | -88.34 | -82.46 | -76.55 | -75.69 | Upgrade
|
| Total Debt Repaid | -84.21 | -88.34 | -82.46 | -76.55 | -75.69 | Upgrade
|
| Net Debt Issued (Repaid) | -84.21 | -88.34 | -82.46 | -76.55 | -75.69 | Upgrade
|
| Issuance of Common Stock | 24.61 | 133.7 | 18.31 | 3.61 | 24.01 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -1,103 | Upgrade
|
| Dividends Paid | -1,730 | -1,618 | -1,941 | -1,833 | -1,634 | Upgrade
|
| Other Financing Activities | 0 | - | -2.9 | 0 | 0 | Upgrade
|
| Financing Cash Flow | -1,790 | -1,573 | -2,008 | -1,906 | -2,789 | Upgrade
|
| Foreign Exchange Rate Adjustments | -5.41 | 6.89 | -7.09 | -20.35 | 10.95 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | 0 | 0 | 0 | - | Upgrade
|
| Net Cash Flow | 782.47 | -7,586 | 8,263 | -1,415 | -2,227 | Upgrade
|
| Free Cash Flow | 12,653 | 3,842 | -7,812 | -180.15 | 7,660 | Upgrade
|
| Free Cash Flow Growth | 229.34% | - | - | - | -33.92% | Upgrade
|
| Free Cash Flow Margin | 20.24% | 5.26% | -9.60% | -0.22% | 10.29% | Upgrade
|
| Free Cash Flow Per Share | - | 356.01 | -724.50 | -16.71 | 701.12 | Upgrade
|
| Cash Interest Paid | 3.88 | 4.24 | 3.02 | 2.1 | 1.53 | Upgrade
|
| Cash Income Tax Paid | 812.44 | 3,792 | 12,140 | 3,383 | 2,274 | Upgrade
|
| Levered Free Cash Flow | 11,770 | 3,630 | 2,092 | -2,709 | 6,243 | Upgrade
|
| Unlevered Free Cash Flow | 11,772 | 3,632 | 2,094 | -2,707 | 6,244 | Upgrade
|
| Change in Working Capital | 1,833 | 395.21 | -819.69 | -6,858 | -3,448 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.